Propranolol treatment of chronically hospitalized aggressive patients

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 11, Issue 3, 1999, Pages 328-335

  Silver, Jonathan M ^a   Yudofsky, Stuart C ^b   Slater, Jonathan A ^b   Gold, Ruth Kugelmass ^b   Katz Stryer, Barri L ^b   Williams, Daniel T ^b   Wolland, Henrietta ^b   Endicott, Jean ^b  

^a LENOX HILL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE; HALOPERIDOL; MESORIDAZINE; PROPRANOLOL; THIORIDAZINE; TIOTIXENE;

ADULT; AGGRESSION; ALOPECIA; ARTICLE; ASTHMA; CLINICAL ARTICLE; DISEASE COURSE; FATIGUE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MENTAL PATIENT; MICTURITION DISORDER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SEIZURE; VERTIGO; VIOLENCE;

EID: 0032876104     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.11.3.328     Document Type: Article

References (30)

1. Tardiff K, Sweillam A: Assaultive behavior among chronic inpatients. Am J Psychiatry 1982; 139:212-215
2. New York State Senate Select Committee on Mental and Physical Handicap: Violence Revisited: A Report on Traditional Indifference in State Mental Institutions Toward Assaultive Activity. Senator James H. Donovan, Chairman, 1977
3. Reid WH, Bollinger MF, Edwards G: Assaults in hospitals. Bull Am Acad Psychiatry Law 1985; 13:1-4
4. Anderson KA, Silver JM: Neurological diseases and medical diseases, in Medical Management of the Violent Patient: Clinical Assessment and Therapy, edited by Tardiff K. New York, Marcel Dekker (in press)
5. Silver JM, Yudofsky SC: Violence and the brain, in Behavioral Neurology and Neuropsychology, edited by Feinberg TE, Farah MJ. New York, McGraw-Hill, 1997, pp 711-717
6. Silver JM, Yudofsky SC: Aggressive disorders, in Neuropsychiatry of Traumatic Brain Injury, edited by Silver JM, Yudofsky SC, Hales RE. Washington, DC, American Psychiatric Press, 1994, pp 313-356
7. Yudofsky SC, Silver JM, Hales RE: Treatment of agitation and aggression, in American Psychiatric Press Textbook of Psychopharmacology, 2nd edition, edited by Schatzberg AF, Nemeroff CB. Washington, DC, American Psychiatric Press, 1998, pp 881-900
8. Brooke MM, Patterson DR, Questad KA, et al: The treatment of agitation during initial hospitalization after traumatic brain injury. Arch Phys Med Rehabil 1992; 73:917-921
9. Greendyke RM, Kanter DR, Schuster DB, et al: Propranolol treatment of assaultive patients with organic brain disease: a double-blind crossover, placebo-controlled study. J Nerv Ment Dis 1986; 174:290-294
10. Mattes JA: Comparative effectiveness of carbamazepine and propranolol for rage outbursts. J Neuropsychiatry Clin Neurosci 1990; 2:159-164
11. Ratey JJ, Sorgi P, O'Driscoll GA, et al: Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a double-blind, placebo-controlled study. J Clin Psychiatry 1992; 53:41-46
12. Alpert M, Allan ER, Citrome L, et al: A double-blind, placebo-controlled study of adjunctive nadolol in the management of violent psychiatric patients. Psychopharmacol Bull 1990; 28:367-371
13. Greendyke RM, Kanter DR: Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study. J Clin Psychiatry 1986; 47:423-426
14. Yudofsky SC, Silver JM, Jackson W, et al: The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986; 143:35-39
15. Silver JM, Yudofsky SC: Documentation of aggression in the assessment of the violent patient. Psychiatric Annals 1987; 17:375-384
16. Silver JM, Yudofsky SC: The Overt Aggression Scale: overview and guiding principles. J Neuropsychiatry Clin Neurosci 1991; 3(suppl):S22-S29
17. Silver JM, Yudofsky SC: Propranolol in the treatment of chronically hospitalized patients, in Biological Psychiatry, edited by Shagass C, Josiassen RC, Bridger WH, et al. New York, Elsevier, 1986, pp 174-176
18. Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35:837-844
19. Endicott J, Spitzer RL, Fleiss J, et al: The Global Assessment Scales: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33:766-771
20. Silver JM, Yudofsky SC, Kogan M, et al: Elevation of thioridazine plasma levels by propranolol. Am J Psychiatry 1986; 143:1290-1292
21. Knoedler DW: The modified Overt Aggression Scale (letter). Am J Psychiatry 1989; 146:1081-1082
22. Hegstrand LR, Eichelman B: Increased shock-induced fighting with supersensitive β-adrenergic receptors. Pharmacol Biochem Behav 1983; 19:313-320
23. Leavitt ML, Yudofsky SC, Maroon JC, et al: Effect of intraventricular nadolol infusion on shock-induced aggression in 6-hydroxydopamine-treated rats. J Neuropsychiatry Clin Neurosci 1989; 1:167-172
24. Weiler PG, Mungas D, Bernick C: Propranolol for the control of disruptive behavior in senile dementia. J Geriatr Psychiatry Neurol 1988; 1:226-230
25. Sorgi PJ, Ratey JJ, Polakoff S: β-adrenergic blockers in the control of aggressive behaviors in patients with chronic schizophrenia. Am J Psychiatry 1986; 143:775-776
26. Gengo FM, Fagan SC, de Padova A, et al: The effect of β-blockers on mental performance on older hypertensive patients. Arch Intern Med 1988; 148:779-784
27. Silver JM, Yudofsky SC, Hurowitz GI: Psychopharmacology and electroconvulsive therapy, in American Psychiatric Press Synopsis of Psychiatry, edited by Hales RE, Yudofsky SC. Washington, DC, American Psychiatric Press, 1996, pp 837-946
28. Adler LA, Angrist B, Reiter S, et al: Neuroleptic-induced akathisia: a review. Psychopharmacology 1989; 97:1-11
29. Sorgi P, Ratey J, Knoedler D, et al: Depression during treatment with beta-blockers: results from a double-blind placebo-controlled study. J Neuropsychiatry Clin Neurosci 1992; 4:187-189
30. Yudofsky SC: β-Blockers and depression: the clinician's dilemma. JAMA 1992; 267:1826-1827